Catalog 01 Resources 02 How to order 03 CalculatorBlog Cart 03 Home 04
Recovery & Repair

VIP Australia — Vasoactive Intestinal Peptide, 10 mg

VIP research peptide vial — TXLABS, ≥98% HPLC

From $139 AUD · ≥98% HPLC purity · third-party COA · ships Australia-wide

What is VIP?

VIP (vasoactive intestinal peptide) is a 28-amino-acid neuropeptide that acts on VPAC receptors as a vasodilator and immunomodulator. It is studied in research on smooth muscle relaxation, circadian signalling, neuroprotection and inflammatory pathways.

Specifications

What the research covers

VIP, vasoactive intestinal peptide, is a 28-residue neuropeptide catalogued in UniProt as P01282, with the sequence His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2. It carries a C-terminal amide, which is not a stabilising modification added by a manufacturer but part of the native structure, generated in vivo by enzymatic amidation of a glycine-extended precursor.

VIP belongs to the secretin and glucagon peptide superfamily, which makes it structurally related to PACAP, secretin, glucagon and by extension to the incretin peptides stocked elsewhere in this catalogue. It acts at two class B1 G protein-coupled receptors, VPAC1 and VPAC2, encoded by VIPR1 and VIPR2. Published work has examined VIP in a wide range of physiological contexts including smooth muscle relaxation, vasodilation, secretory regulation in the gastrointestinal tract, circadian signalling in the suprachiasmatic nucleus, and immunomodulatory functions; it is a well-characterised endogenous peptide with a large and long-established literature, which distinguishes it from most of the compounds around it here.

Three residues determine how the molecule degrades, and knowing which they are makes stability planning straightforward rather than guesswork. The methionine at position 17 is the single most oxidation-sensitive site. The asparagine and glutamine residues, of which there are several including two asparagines near the C-terminus, are deamidation-prone. And the C-terminal amide itself can hydrolyse to the free acid, a change of about one dalton that matters because the published structure-activity literature indicates the amide is required for receptor activity.

TXLABS supplies VIP as an analytical reference material for laboratory research only. It is not an approved therapeutic good in Australia and is not supplied for human or veterinary administration.

Reading the certificate

Three specific species should be excluded on a certificate for VIP, and they are all predictable from the sequence. Methionine sulfoxide adds sixteen daltons and is the classic degradation product; it is the first thing to look for on a mass spectrum and it usually elutes slightly earlier than the parent on reversed-phase. Deamidated species add about one dalton and arise at the asparagine and glutamine positions, requiring reasonable mass accuracy to see. And the des-amido C-terminal form, also about one dalton heavier, matters more than its size suggests because the published structure-activity work indicates the amide is required for receptor activity, so a des-amido impurity is not a minor variant. Ask which of the three the certificate actually addressed. TXLABS publishes third-party certificates for tested lots in the CoA library; none is published for VIP, and the lot certificate is supplied on request to support@txlabs.bio.

Storage and handling

The methionine sets the storage priorities. Methionine oxidises to the sulfoxide readily in the presence of dissolved oxygen, peroxide traces in solvents, and metal ion catalysis, so minimising headspace, avoiding aged solvent stocks and keeping solutions cold and dark are substantive controls for this peptide rather than general precautions. Deamidation of the asparagine and glutamine residues is the second route and accelerates at elevated pH and temperature, which argues against holding VIP in alkaline buffers. The dry cake is held at -20 °C under desiccant and away from light, and a chilled vial should reach ambient temperature still sealed before the closure is broken. Reconstituted solution goes to 2-8 °C in single-use aliquots. At 28 residues VIP has enough amphipathic character to adsorb to surfaces at low concentration, so low-binding plasticware is worth using. Australian summer transit above 40 °C accelerates both oxidation and deamidation simultaneously; a parcel collected promptly and refrigerated avoids a degradation profile that no later handling can undo.

Working out concentration

VIP is stocked in a 10 mg vial. Reconstituted with 1 mL of bacteriostatic water it gives 10 mg/mL; with 2 mL, 5 mg/mL; with 5 mL, 2 mg/mL; with 10 mL, 1 mg/mL. Two tyrosine residues and a phenylalanine give VIP a usable absorbance near 280 nm, so a spectrophotometric estimate against a calculated extinction coefficient offers an independent check on the arithmetic, which is worth doing for a peptide where surface adsorption can reduce the actual concentration below the calculated one. Any large discrepancy points to incomplete dissolution or loss to container walls. The calculator handles the division. Concentration examples only, not a protocol.

How it relates to adjacent compounds

VIP's superfamily relationship is the useful one here: it belongs to the secretin and glucagon peptide family, which makes it a structural relative of the incretin analogues stocked in this catalogue including semaglutide and retatrutide, both of which act at class B1 receptors of the same broad architecture. That relationship is one of shared ancestry and receptor class, not of interchangeability. SS-31 is a useful comparison of a different kind, as another peptide whose stability profile is dominated by a single oxidation-sensitive residue, which makes the two similar in what their storage conditions have to protect against. These are structural and analytical relationships, described because they bear on handling and certification, and they imply nothing about comparative activity.

Frequently asked questions

Why is the C-terminal amide important? +
Because it is part of the native molecule and, according to the published structure-activity literature, required for receptor activity. It is produced in vivo by enzymatic amidation of a glycine-extended precursor rather than being a synthetic stabilisation. That means a des-amido impurity is not a cosmetic variation but a species with different pharmacology, despite differing from the target by only about one dalton.
What is methionine sulfoxide and why does it matter here? +
It is the oxidation product of methionine, sixteen daltons heavier than the parent residue. VIP contains a methionine at position 17, which makes it the most oxidation-sensitive site in the molecule. Sulfoxide formation is promoted by dissolved oxygen, peroxide traces in solvents and metal ion catalysis, and it is the first degradation product to look for on a mass spectrum of stored VIP.
Which peptide family does VIP belong to? +
The secretin and glucagon superfamily, which also includes PACAP, secretin, glucagon and the GLP-1 family. Members share a common structural architecture and act at class B1 G protein-coupled receptors. VIP acts at VPAC1 and VPAC2, encoded by VIPR1 and VIPR2. The relationship is one of evolutionary ancestry and receptor class, not of overlapping selectivity.
How is VIP different from most compounds in this catalogue? +
It is a well-characterised endogenous human peptide with a long-established literature, rather than a compound whose evidence base is thin or concentrated in a few groups. Its sequence, receptors, tissue distribution and physiology have been studied across decades in the mainstream peer-reviewed literature. That makes it unusually well documented for something sold as a research reference material here.
Can VIP's concentration be checked spectrophotometrically? +
Yes, and it is worth doing. Two tyrosines and a phenylalanine give a usable absorbance near 280 nm, so an ultraviolet reading against a calculated extinction coefficient provides an independent estimate of concentration. That cross-check matters more than usual for VIP because the peptide adsorbs to container surfaces at low concentration, meaning the prepared and actual concentrations can diverge.
What is VIP's regulatory position in Australia? +
It is not registered on the ARTG. Scheduling sits in the Poisons Standard, which the TGA revises on a regular cycle, so status is date-dependent and should be read from the current instrument rather than assumed. The TGA has published guidance on the obligations attaching to importing, compounding and supplying unapproved peptide products. Consult tga.gov.au for the position that applies.

Related compounds

Browse full catalog Reconstitution calculator